Sherin is a member of the Practice Area Patents Technology & Life Sciences. She advises national and international companies on general issues of medical device law and pharmaceutical law, in particular with regard to regulatory issues. Her practice focuses on life sciences.

显示完整简历 隐藏完整简历

最新新闻和观点

专利与创新

OLG Celle on the obligations of distributors under Art. 14 MDR when distributing non-compliant medical devices in the context of unfair competition law

2023年3月22日
Briefing

作者 Dr. Daniel Tietjen 以及 Sherin Sayed

点击此处了解更多
酒店与休闲

Long-running issue: the distinction between cosmetic products and medicinal products by function

2022年12月15日
Briefing

作者 Dr. Manja Epping 以及 Sherin Sayed

点击此处了解更多
酒店与休闲

Higher Regional Court of Hamm on the advertising ban in Sec. 12 HWG in the context of the COVID 19 pandemic

2023年3月22日
Briefing

作者 Dr. Daniel Tietjen 以及 Katharina Hölle

点击此处了解更多
公司/并购与资本市场

Taylor Wessing advises Emerald Technology Ventures on investment in Colibri Energy

With this investment, Emerald Technology Ventures supports the development and growth of Colibri Energy, a provider of lithium-ion battery systems for vehicles in airport and industrial logistics.

2023年3月22日

作者

点击此处了解更多

与我会面: